Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Flow cytometric analysis of EBUS-TBNA samples v1

View through CrossRef
1) First preparation ・Sample is collected in 5% FBS in 1 ml DMEM high glucose. ・Transfer the sample to a 15 ml centrifuge tube and add PBS containing 10% wash and recovery solution (CELLOTION®, Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan) to a 10 ml volume. ・For washing, mix by inversion, centrifuge at 150 xg for 5 minutes, discard the supernatant. ① ・Remove sample from the 15 ml centrifuge tube, cut it on a petri dish, return it to the 15 ml centrifuge tube, add PBS and mix. ・Wash again as in ①. ・For hemolysis, add erythrocyte lysing reagent without fixative (EasyLyse® Agilent Technologies, Inc., CA, USA), mix by overturning and allow it to react for 15 minutes at room temperature. ・Add PBS and wash as in ①. ・Add PBS to the sample and filtrate to a 50 μl centrifuge tube. ・Centrifuge at 1200 rpm for 5 minutes, discard the supernatant leaving 1 ml. ・Dispense 6 μl, stain with trypan blue and count the number of cells. ・Dispense 50 – 100 μl into each of 8 microtubes for 2 Negative Controls, CD3/CD4/CD8, CD3/CD19, CD4, CD25, FoxP3, and Treg staining. ・Centrifuge at 1200 rpm for 5 minutes and discard the supernatant. Add 90 μl of 0.5% BSA in PSA to each microtube. 2) Measurement of CD4/CD8 ratio and CD3/CD19 ratio ・10 μl of anti-CD3 + anti-CD4 + anti-CD8 antibodies (CD4-FITC/CD8-PE/CD-3-PC5; Beckman Coulter, Inc., CA, diluted 1: 10) was added to the microtube for CD3/CD4/CD8, and anti-CD3 + anti-CD19 antibodies (CD3-FITC/CD-19-PE; Beckman Coulter, Inc., diluted 1: 10) was added to the CD3/CD19 microtube. ・React the three microtubes with one NC at room temperature for 15 minutes. ・Add 1 ml of PBS, centrifuge at 1200 rpm for 5 minutes, transfer to a FC tube and perform flow cytometry. 3) Measurement of regulatory T cells (Treg). ・Treg were measured using a Treg Detection Kit (CD4/CD25/FoxP3 APC), human® (Miltenyi Biotec Inc., Bergisch, Gladbach, Germany). ・Add 5 μl of anti-CD4 (VIT 4)-FITC antibodies (diluted 1:10) contained in the kit to the CD4 microtube and 10 μl to the Treg microtube. ・Add 5 μl of anti-CD25 (4E3)-PE antibodies (diluted 1: 10) contained in the kit to the CD25 microtube and 10 μl to the Treg microtube. ・Three microtubes to which antibody has been added are reacted at 4°C for 10 minutes, then 1 ml of 0.5% BSA in PBS is added, followed by centrifugation at 1200 rpm for 5 minutes, and the supernatant is removed. ・Add 500 μl of Fix Buffer contained in the kit to each of 5 microtubes containing the Negative Control and FoxP3 microtubes for fixation and drilling of cells, and react for 30 minutes at 4°C in the dark. ・Centrifuge at 1200 rpm for 5 minutes, remove the supernatant, add 1 ml Permeabilization Buffer contained in the kit, centrifuge again at 1200 rpm for 5 minutes and remove the supernatant. ・Add 80 μl of Permeabilization Buffer contained in the kit to each microtube, then add 20 μl of Blocking Buffer to the Treg microtube and 10 μl to the other microtubes and react at 4°C for 5 minutes. ・Add 5 μl anti-FoxP3 (3G 3)-APC antibodies (diluted 1: 10) contained in the kit to the FoxP3 microtube and 10 μl to the Treg microtube, and react at 4°C for 5 minutes. ・Add 1 ml Permeabilization Buffer to each microtube, centrifuge at 1,500 rpm for 5 minutes, transfer t
Title: Flow cytometric analysis of EBUS-TBNA samples v1
Description:
1) First preparation ・Sample is collected in 5% FBS in 1 ml DMEM high glucose.
・Transfer the sample to a 15 ml centrifuge tube and add PBS containing 10% wash and recovery solution (CELLOTION®, Nippon Zenyaku Kogyo Co.
, Ltd.
, Fukushima, Japan) to a 10 ml volume.
・For washing, mix by inversion, centrifuge at 150 xg for 5 minutes, discard the supernatant.
① ・Remove sample from the 15 ml centrifuge tube, cut it on a petri dish, return it to the 15 ml centrifuge tube, add PBS and mix.
・Wash again as in ①.
・For hemolysis, add erythrocyte lysing reagent without fixative (EasyLyse® Agilent Technologies, Inc.
, CA, USA), mix by overturning and allow it to react for 15 minutes at room temperature.
・Add PBS and wash as in ①.
・Add PBS to the sample and filtrate to a 50 μl centrifuge tube.
・Centrifuge at 1200 rpm for 5 minutes, discard the supernatant leaving 1 ml.
・Dispense 6 μl, stain with trypan blue and count the number of cells.
・Dispense 50 – 100 μl into each of 8 microtubes for 2 Negative Controls, CD3/CD4/CD8, CD3/CD19, CD4, CD25, FoxP3, and Treg staining.
・Centrifuge at 1200 rpm for 5 minutes and discard the supernatant.
Add 90 μl of 0.
5% BSA in PSA to each microtube.
2) Measurement of CD4/CD8 ratio and CD3/CD19 ratio ・10 μl of anti-CD3 + anti-CD4 + anti-CD8 antibodies (CD4-FITC/CD8-PE/CD-3-PC5; Beckman Coulter, Inc.
, CA, diluted 1: 10) was added to the microtube for CD3/CD4/CD8, and anti-CD3 + anti-CD19 antibodies (CD3-FITC/CD-19-PE; Beckman Coulter, Inc.
, diluted 1: 10) was added to the CD3/CD19 microtube.
・React the three microtubes with one NC at room temperature for 15 minutes.
・Add 1 ml of PBS, centrifuge at 1200 rpm for 5 minutes, transfer to a FC tube and perform flow cytometry.
3) Measurement of regulatory T cells (Treg).
・Treg were measured using a Treg Detection Kit (CD4/CD25/FoxP3 APC), human® (Miltenyi Biotec Inc.
, Bergisch, Gladbach, Germany).
・Add 5 μl of anti-CD4 (VIT 4)-FITC antibodies (diluted 1:10) contained in the kit to the CD4 microtube and 10 μl to the Treg microtube.
・Add 5 μl of anti-CD25 (4E3)-PE antibodies (diluted 1: 10) contained in the kit to the CD25 microtube and 10 μl to the Treg microtube.
・Three microtubes to which antibody has been added are reacted at 4°C for 10 minutes, then 1 ml of 0.
5% BSA in PBS is added, followed by centrifugation at 1200 rpm for 5 minutes, and the supernatant is removed.
・Add 500 μl of Fix Buffer contained in the kit to each of 5 microtubes containing the Negative Control and FoxP3 microtubes for fixation and drilling of cells, and react for 30 minutes at 4°C in the dark.
・Centrifuge at 1200 rpm for 5 minutes, remove the supernatant, add 1 ml Permeabilization Buffer contained in the kit, centrifuge again at 1200 rpm for 5 minutes and remove the supernatant.
・Add 80 μl of Permeabilization Buffer contained in the kit to each microtube, then add 20 μl of Blocking Buffer to the Treg microtube and 10 μl to the other microtubes and react at 4°C for 5 minutes.
・Add 5 μl anti-FoxP3 (3G 3)-APC antibodies (diluted 1: 10) contained in the kit to the FoxP3 microtube and 10 μl to the Treg microtube, and react at 4°C for 5 minutes.
・Add 1 ml Permeabilization Buffer to each microtube, centrifuge at 1,500 rpm for 5 minutes, transfer t.

Related Results

EBUS
EBUS
El EBUS (EndoBronchial Ultrasound) o Ecobroncoscopia es una técnica minimamente invasiva que utiliza Ultrasonidos, al mismo tiempo que la visión endoscópica, para valoración de alt...
Echinococcus granulosus in Environmental Samples: A Cross-Sectional Molecular Study
Echinococcus granulosus in Environmental Samples: A Cross-Sectional Molecular Study
Abstract Introduction Echinococcosis, caused by tapeworms of the Echinococcus genus, remains a significant zoonotic disease globally. The disease is particularly prevalent in areas...
Multiphase Flow Metering:An Evaluation of Discharge Coefficients
Multiphase Flow Metering:An Evaluation of Discharge Coefficients
Abstract The orifice discharge coefficient (CD) is the constant required to correct theoretical flow rate to actual flow rate. It is known that single phase orifi...
Pressure Analysis of DST Flow Period Or Slug Flow For Horizontal Wells In Homogeneous Reservoir
Pressure Analysis of DST Flow Period Or Slug Flow For Horizontal Wells In Homogeneous Reservoir
Abstract By the transient pressure for horizontal well with constant flow rate and Duhamel's principle, this paper presents the method to calculate the transient ...
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
AbstractIntroductionIn patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protective of future ischemic cerebral events. Reserve cerebral ...
A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).
A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).
Abstract In about 30% of patients with AML the predominantly nucleolar protein nucleophosmin (NPM1) is dislocated into the cytoplasm (NPM1c), caused by mutations in ...
Experimental and Numerical Analysis of the Flow Field in the Integrated Valve for the Control Rod Hydraulic Drive System
Experimental and Numerical Analysis of the Flow Field in the Integrated Valve for the Control Rod Hydraulic Drive System
Control Rod Hydraulic Drive System (CRHDS) is a new type of built-in control rod drive technology, and the Integrated Valve (IV) is the key control component of it. The pulse water...

Back to Top